Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients.
Publication/Presentation Date
5-1-2022
Abstract
BACKGROUND: Surgical ventricular reconstruction (SVR) has been used to control adverse ventricular remodeling and improve cardiac function in ischemic cardiomyopathy. The purpose of this systematic review and meta-analysis was to collect and analyze all available evidence on the utilization and efficacy of SVR.
METHODS: An electronic database search was performed to identify all retrospective and prospective studies on SVR for ischemic cardiomyopathy in the English literature from 2000 through 2020. A total of 92 articles with a collective 7,685 patients undergoing SVR were included in the final analysis.
RESULTS: The mean patient age was 61 years (95% CI: 59-63) and 80% (78-82%) were male. Congestive heart failure was present in 66% (54-78%) and angina in 58% (45-70%). Concomitant coronary artery bypass grafting was undertaken in 92% (90-93%) while 21% (18-24%) underwent mitral valve repair. Pre
CONCLUSIONS: In patients with ischemic cardiomyopathy, SVR reduces left ventricular volumes and improves systolic function leading to symptomatic improvement.
Volume
11
Issue
3
First Page
226
Last Page
238
ISSN
2225-319X
Published In/Presented At
Ferrell, B. E., Jimenez, D. C., Ahmad, D., Malkani, K., Rosen, J. L., Gaw, G., Plestis, K. A., Guy, T. S., Massey, H. T., & Tchantchaleishvili, V. (2022). Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients. Annals of cardiothoracic surgery, 11(3), 226–238. https://doi.org/10.21037/acs-2021-ami-17
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
35733719
Department(s)
Administration and Leadership
Document Type
Article